Key research & article

Last updated: 2024 Apr 18

Total hit(s): 5158

S.No.
1	38512394	Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.	Hum Vaccin Immunother	2024 Dec 31	4.7	1
2	38361363	Serological assessment of the durability of vaccine-mediated protection against SARS-CoV-2 infection.	Hum Vaccin Immunother	2024 Dec 31	4.7	1
3	38304547	Binding affinity between coronavirus spike protein and human ACE2 receptor.	Comput Struct Biotechnol J	2024 Dec	5.11	1
4	38550333	Investigation of phytochemicals isolated from selected Saudi medicinal plants as natural inhibitors of SARS CoV-2 main protease: In vitro, molecular docking and simulation analysis.	Saudi Pharm J	2024 May	5.6	1
5	38592189	Prediction of deleterious non-synonymous SNPs of TMPRSS2 protein combined with Molecular Dynamics Simulations and free energy analysis to identify the potential peptide substrates against SARS-CoV-2.	J Biomol Struct Dyn	2024 Apr 9	3.22	1
6	38589848	Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza.	Virol J	2024 Apr 9	2.45	1
7	38591877	Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.	J Virol	2024 Apr 9	4.16	1
8	38599653	Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study.	RMD Open	2024 Apr 9	6.1	1
9	38593595	Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication.	Virology	2024 Apr 8	2.819	1
10	38581432	What is the economic benefit of annual COVID-19 vaccination from the adult individual perspective?	J Infect Dis	2024 Apr 6	4.73	1
11	38576396	Antibiotics daptomycin interacts with S protein of SARS-CoV-2 to promote cell invasion of omicron (B1.1.529) pseudovirus.	Virulence	2024 Apr 5	4.81	1
12	38497901	Synthesis and immunological evaluation of TLR1/2 ligand-conjugated RBDs as self-adjuvanting vaccine candidates against SARS-CoV-2.	Chem Commun (Camb)	2024 Apr 4	10.1	1
13	38608595	In vitro pharmacokinetic behavior in lung of harringtonine, an antagonist of SARS-CoV-2 associated proteins: New insights of inhalation therapy for COVID-19.	Phytomedicine	2024 Apr 4	7.2	1
14	38573524	Specific features of epitope-MIPs and whole-protein MIPs as illustrated for AFP and RBD of SARS-CoV-2.	Mikrochim Acta	2024 Apr 4	10.1	1
15	38575433	Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults: A phase 3, randomized, active-controlled, multicenter trial.	Vaccine	2024 Apr 3	3.31	1
16	38570605	Immunogenicity and efficacy of VLA2001 vaccine against SARS-CoV-2 infection in male cynomolgus macaques.	Commun Med (Lond)	2024 Apr 3		1
17	38570577	Seroepidemiological assessment of SARS-CoV-2 vaccine responsiveness and associated factors in the vaccinated community of the Casablanca-Settat Region, Morocco.	Sci Rep	2024 Apr 3	4.12	1
18	38617283	Predicting Functional Conformational Ensembles and Binding Mechanisms of Convergent Evolution for SARS-CoV-2 Spike Omicron Variants Using AlphaFold2 Sequence Scanning Adaptations and Molecular Dynamics Simulations.	bioRxiv	2024 Apr 3	- n/a -	1
19	38617221	Distal Protein-Protein Interactions Contribute to SARS-CoV-2 Main Protease Substrate Binding and Nirmatrelvir Resistance.	bioRxiv	2024 Apr 2	- n/a -	1
20	38564431	Self-Assembling Sulfated Lactobacillus Exopolysaccharide Nanoparticles as Adjuvants for SARS-CoV-2 Subunit Vaccine Elicit Potent Humoral and Cellular Immune Responses.	ACS Appl Mater Interfaces	2024 Apr 2	14.4	1
21	38565881	SARS-CoV-2 variant with the spike protein mutation F306L in the southern border provinces of Thailand.	Sci Rep	2024 Apr 2	4.12	1
22	38632526	The plasma proteome differentiates the multisystem inflammatory syndrome in children (MIS-C) from children with SARS-CoV-2 negative sepsis.	Mol Med	2024 Apr 17	6.9	1
23	38631949	Safe plant Hsp90 adjuvants elicit an effective immune response against SARS-CoV2-derived RBD antigen.	Vaccine	2024 Apr 17	3.31	1
24	38597182	Enteric coronavirus nsp2 is a virulence determinant that recruits NBR1 for autophagic targeting of TBK1 to diminish the innate immune response.	Autophagy	2024 Apr 16	10.79	1
25	38624232	Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein.	J Virol	2024 Apr 16	4.16	1